Portal de investigación
Challenges and perspectives in obstructive sleep apnoea Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Randerath, W
- Bassetti, CL
- Bonsignore, MR
- Farre, R
- Ferini-Strambi, L
- Grote, L
- Hedner, J
- Kohler, M
- Mihaicuta, S
- Montserrat, J
- Pepin, JL
- Pevernagie, D
- Pizza, F
- Polo, O
- Riha, R
- Ryan, S
- Verbraecken, J
- McNicholas, WT
Grupos
Abstract
Obstructive sleep apnoea (OSA) is a major challenge for physicians and healthcare systems throughout the world. The high prevalence and the impact on daily life of OSA oblige clinicians to offer effective and acceptable treatment options. However, recent evidence has raised questions about the benefits of positive airway pressure therapy in ameliorating comorbidities. An international expert group considered the current state of knowledge based on the most relevant publications in the previous 5 years, discussed the current challenges in the field, and proposed topics for future research on epidemiology, phenotyping, underlying mechanisms, prognostic implications and optimal treatment of patients with OSA. The group concluded that a revision to the diagnostic criteria for OSA is required to include factors that reflect different clinical and pathophysiological phenotypes and relevant comorbidities (e.g. nondipping nocturnal blood pressure). Furthermore, current severity thresholds require revision to reflect factors such as the disparity in the apnoea-hypopnoea index (AHI) between polysomnography and sleep studies that do not include sleep stage measurements, in addition to the poor correlation between AHI and daytime symptoms such as sleepiness. Management decisions should be linked to the underlying phenotype and consider outcomes beyond AHI.
Datos de la publicación
- ISSN/ISSNe:
- 0903-1936, 1399-3003
- Tipo:
- Review
- Páginas:
- -
- PubMed:
- 29853491
- Factor de Impacto:
- 3,925 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
EUROPEAN RESPIRATORY JOURNAL EUROPEAN RESPIRATORY SOC JOURNALS LTD
Citas Recibidas en Web of Science: 131
Documentos
- No hay documentos
Filiaciones
Keywords
- POSITIVE AIRWAY PRESSURE; MANDIBULAR ADVANCEMENT DEVICE; EXCESSIVE DAYTIME SLEEPINESS; QUALITY-OF-LIFE; IDIOPATHIC PULMONARY-FIBROSIS; RANDOMIZED CONTROLLED-TRIAL; FATTY LIVER-DISEASE; NON-CPAP THERAPIES; BLOOD-PRESSURE; GENERAL-POPULATION
Proyectos y Estudios Clínicos
INTENSIFICACION DR. MIGUEL MARTINEZ GARCIA
Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA
INT11/037 . 2012
ASOCIACION ENTRE TRASTORNOS RESPIRATORIOS DEL SUEÑO Y TASA DE CRECIMIENTO DEL MELANOMA CUTANEO
Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA
PI12/01363 . INSTITUTO DE SALUD CARLOS III . 2013
EFECTO DEL TRATAMIENTO CON CPAP SOBRE LAS CIFRAS TENSIONALES EN PACIENTES CON HIPERTENSION ARTERIAL REFRACTARIA. ESTUDIO MULTICENTRICO Y ALEATORIZADO. ESTUDIO HIPARCO
Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA
PI09/01647 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010
INTENSIFICACION DR. MIGUEL ANGEL MARTINEZ GARCIA
Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA
INT14/00003 . INSTITUTO DE SALUD CARLOS III . 2015
ASOCIACIÓN ENTRE LOS TRASTORNOS RESPIRATORIOS DEL SUEÑO Y EL PRONÓSTICO DEL MELANOMA. ESTUDIO LONGITUDINAL Y MULTICÉNTRICO EN 443 PACIENTES CON MELANOMA CUTÁNEO MALIGNO.
Investigador Principal: MIGUEL ÁNGEL MARTÍNEZ GARCÍA
PI16/01772 . INSTITUTO DE SALUD CARLOS III . 2017
Cita
Randerath W,Bassetti CL,Bonsignore MR,Farre R,Ferini L,Grote L,Hedner J,Kohler M,Martinez MA,Mihaicuta S,Montserrat J,Pepin JL,Pevernagie D,Pizza F,Polo O,Riha R,Ryan S,Verbraecken J,McNicholas WT. Challenges and perspectives in obstructive sleep apnoea Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society. Eur Respir J. 2018. 52(3):1702616. IF:11,807. (1).